Controversies in perioperative medicine

Western Journal of Medicine

Volumn 169, Issue 6, 1998, Pages 351-355

  Cheng, Hugo Quinny ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CEFADROXIL; CEFALEXIN; CEFAZOLIN; CLINDAMYCIN; HEPARIN; INSULIN; PLACEBO; VANCOMYCIN; WARFARIN;

ACUTE HEART INFARCTION; ANTIBIOTIC PROPHYLAXIS; ANTICOAGULANT THERAPY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; ENDOCARDITIS; GLUCOSE BLOOD LEVEL; HEART VALVE PROSTHESIS; HUMAN; INSULIN TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; META ANALYSIS; ORAL DRUG ADMINISTRATION; PERIOPERATIVE PERIOD; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL; SURGICAL PATIENT; THROMBOEMBOLISM;

ADRENERGIC BETA-ANTAGONISTS; ANTICOAGULANTS; BLOOD GLUCOSE; DIABETES MELLITUS; DISEASE; ENDOCARDITIS, BACTERIAL; GUIDELINES; HEART DISEASES; HEART VALVE PROSTHESIS; HUMANS; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; SURGICAL PROCEDURES, OPERATIVE;

EID: 0032424279     PISSN: 00930415     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Durack DT. Prevention of infective endocarditis. N Enal J Med 1995; 332:38-44
2. Dajani AS, Taubert KA, Wilson W, el al. Prevention of bacterial endocarditis: recommendations by the American Heart Association. JAMA 1997:277:1794-1801
3. van der Meer JT, Thompson J, Valkenburg HA, Michel MF. Epidemiology of bacterial endocarditis in The Netherlands. II. Antecedent procedures and use of prophylaxis. Arch Intern Med 1992; 152:1869-1873
4. Horstkotte D, Rosin H, Friedrichs W, Loogen F. Contribution for choosing the optimal prophylaxis of bacterial endocarditis. Eur Heart J 1987; 8(supp J): 379-381
5. Imperiale TF, Horwitz RI. Does prophylaxis prevent postdental infective endocarditis? A controlled evaluation of protective efficacy. Am J Med 1990; 88:131-136
6. van der Meer JT, van Wijk W, Thompson J, Vandenbroucke JP, Valkenburg HA, Michel MF. Efficacy of antibiotic prophylaxis for prevention of native-valve endocarditis. Lancet 1992; 339:135-139
7. Clemens JD, Ransohoff DF. A quantitative assessment of pre-dental antibiotic prophylaxis for patients with mitral-valve prolapse. J Chron Dis 1984; 37:531-544
8. Cannegieter SC, Rosendaal FR, Briet E. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation 1994; 89:635-641
9. Kearon C, Hirsh J. Management of anticoagulation before and after elective surgery. N Engl J Med 1997; 336:1506-1511
10. Eckman MH, Beshansky JR, Durand-Zaleski I, Levine HJ, Pauker SG. Anticoagulation for noncardiac procedures in patients with prosthetic valves. Docs low risk mean high cost? JAMA 1990; 263:1513-1521
11. Katholi RE, Nolan SP, McGuire LB. Living with prosthetic heart valves: subsequent noncardiac operations and the risk of thromboembolism or hemorrhage. Am Heart J 1976; 92:162-167
12. Katholi RE, Nolan SP, McGuire LB. The management of anticoagulation during noncardiac operations in patients with prosthetic heart valves: a prospective study. Am Heart J 1978; 96:163-165
13. Tinker JH, Tarhan S. Discontinuing anticoagulant therapy in surgical patients with cardiac valve prostheses: observations in 180 operations. JAMA 1978:239:738-739
14. Stasnaro-Green A. Perioperative glucose control: does it really matter? Mt Sinai J Med 1991; 58:299-304
15. McMurray JF. Wound healing with diabetes mellitus. Better glucose control for better wound healing in diabetics. Surg Clin North Am 1984; 64:769-778